TrialJournal of gynecologic oncology2023

Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT).

Yang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.